Article Text

Download PDFPDF

Paper
Elective ventilation and the politics of death
  1. Nathan Emmerich
  1. Correspondence to Dr Nathan Emmerich, Visiting Research Fellow, School of Politics, International Politics and Philosophy, Queen's University Belfast, Belfast BT7 1NN, UK; nemmerich01{at}qub.ac.uk

Abstract

This essay comments on the British Medical Association's recent suggestion that protocols for Elective Ventilation (EV) might be revived in order to increase the number of viable organs available for transplant. I suggest that the proposed revival results, at least in part, from developments in the contemporary political landscape, notably the decreasing likelihood of an opt-out system for the UK's Organ Donor Register. I go on to suggest that EV is unavoidably situated within complex debates surrounding the epistemology and ontology of death. Such questions cannot be settled a priori by medical science, bioethics or philosophical reflection. As Radcliffe-Richards suggests, the determination of death has become a moral question, and therefore, now extends into the political arena. I argue for the conclusion that EV, and wider debates about organ donation and the constitution of the organ donation register, are matters of ‘biocitizenship’ and must, therefore, be addressed as ‘biopolitical’ questions.

  • Care of the Dying Patient
  • Cultural Pluralism
  • Death Education
  • Public Policy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

In February 2012, the British Medical Association (BMA) published a report that discussed the current state of organ donation in the UK.1 The report gives an overview of donation rates, the legislative framework and the infrastructure in which donation takes place. Section 4 makes some recommendations regarding how this infrastructure can be developed, and section 5 discuss how the number of donors might be increased. The option of Elective Ventilation (EV) is explored under the heading ‘Expanding the Pool of Potential Donors.’ The other issues discussed under this heading are suggestions the BMA appears to directly support. However, the BMA is not calling for a change in the law so as to permit EV, but for further debate and the assessment of public opinion on the issue.

In some senses, the BMA's position is not dissimilar to that presented in their previous report published in 2000. Here, EV is discussed under the heading ‘Suggestions Requiring Further Consideration.’ However, it concludes that due to ‘practical and ethical difficulties … [EV] is not a viable option at the present time’.2 Yet, compared with the 2012 report, the discussion of EV has a more cautious tone and is more detailed; it explicitly lists a number of safeguards that any EV protocol would require. One might think that between 2000 and 2012 there had been some further development regarding EV in terms of either: further empirical evidence for the claim that EV can increase the number of transplantable organs; more extensive argument regarding the ethics of EV; or the development of a robust protocol to govern EV in clinical practice. However, it seems none of these have occurred. It does not appear that EV is practised in other national contexts, and so, there is no further evidence for its efficacy in producing organs for transplantation. While there has been some scholarly debate about the ethics of EV and comparable practices since 2000, there has been little substantive commentary on the issue.3–7 For instance, a recent edited collection entitled ‘Organ Shortage’ makes one mention of EV and offers no substantive discussion; neither does it merit discussion by Miller and Trugg's recent book-length contribution; and although Radcliffe-Richards offers some thoughts on EV, it is not really considered on its own merit but as part of a broader challenge to the dead donor rule.8–10

Finally, the best available protocol for EV remains that which was developed and used in Exeter in the late 1980s.11 This protocol was developed for the purpose of facilitating organ donation in a district general hospital where scope for rapid retrieval of organs was limited. Over a period of 19 months, the Exeter team used the protocol, albeit with some deviation, to retrieve organs from eight patients, and to no apparent ill effect. However, the practice was discontinued when questions about its legality were raised, and we might also consider whether it is acceptable to introduce such a practice without wider public debate or knowledge. Practices such as EV and organ donation require not only (bio)ethical legitimacy, but also ‘(bio)political’ legitimacy. Our democratic context is one that recognises the validity of moral dissent and dissensus. The social structures and procedural approaches that we adopt to facilitate organ donation should be constructed in such a way as to accommodate the variable ethical perspectives of the polity. As such, they must be considered not only a matter for bioethical debate but also a matter of what I will call biopolitical debate.

While the legal questions about EV may have been resolved by the Mental Capacity Act 2005,12–14 it remains difficult to see what, precisely, has led to the BMA modifying their stance at this point in time. There has been no development in the protocols, no resolution or extended debate about the ethical aspects of EV and, given that changes to the law were not made with EV in mind, its legality must be considered still open to challenge.i During the 12 years since the 2000 report, there have been a number of other changes and developments in organ transplantation practice which may have impacted on the BMA's shifting opinion of EV. Certainly, the number of people in need of an organ transplant has continued to increase, and while the number of available organs has also increased the shortfall continues to grow. It may simply be that, in the light of the continued disparity between the supply and demand for organs, and in the absence of any major practical or ethical objection, the BMA has formed the view that EV should be more actively pursued.

While the disparity in supply and demand continues to grow, there has been some increase in the supply of organs between the 2000 and 2012 reports. This has been, in part, due to the use of a greater number of ‘marginal’ organs and the introduction of protocols for Donation after Circulation/Cardiac Death (DCD). DCD involves the rapid retrieval of organs following a declaration of death based on the cessation of cardiac function, circulation and respiration. Donors may be ‘controlled’ or ‘uncontrolled’, meaning, that death may occur due to planned withdrawal of life-sustaining treatment, or in the context of emergency care. DCD protocols may permit restarting blood circulation following a declaration of death. In such cases, the blood supply to the brain is blocked.15 ,16 As we shall see, the practice of DCD alters the range of possible circumstances in which EV may be deployed and, therefore, its ethical parameters.

A further change to the UK organ donation landscape since the BMA's 2000 report is that the possibility of ‘opt-out’ Organ Donor Register (ODR) came and went, in political terms.ii Current arrangements mean that individuals who wish to donate must register with the ODR; they must opt-in. An opt-out ODR would mean that everyone would be registered automatically. Those who do not wish to donate must remove their names from the register; they must opt-out. As surveys report that many more people in the UK express approval of organ donation (Levitt cites a figure of over 90%) that are registered with the ODR (Levitt suggests it is around 30%), it is hoped that an opt-out arrangement will increase the availability of transplantable organs.17 However, in a 2008 report, the independent Organ Donation Taskforce (ODT) concluded it was not the right time to move to an opt-out system.18 ,19 While the report contained some concrete suggestions for increasing the number of transplantable organs, EV was not among them.

In the lead-up to this report, the then Prime Minister, the Right Honorable Gordon Brown, MP, was seen to be in favour of an opt-out ODR, and for a brief time after its publication it looked as if he would press ahead with an opt-out reform regardless.20 However, the government's position soon became aligned with the ODT's recommendations. We might conclude then that the major change that occurred between the BMA's 2000 and 2012 reports on organ donation is the political landscape. In this timeframe, the possibility of an ODR predicated on an opt-out system has been extensively explored, it has been publicly argued for (and against), politically lobbied for (and against), it became a real political possibility, but it fell at the near-final hurdle of independent recommendation. As it has consistently argued for an opt-out ODR, this must be a source of some regret for the BMA.

There is, of course, nothing wrong with the BMA altering their stance on EV in response to the changing political landscape of organ donation. The contours of political debate and clinical practice condition what is and is not possible for organ donation. In the context of ‘doing everything possible’ to increase the supply of organs, it is perfectly reasonable of the BMA to more actively pursue the practical and ethical implications of EV with a view to instituting it in practice. However, such pragmatism may act to obscure certain aspects of the EV debate and, therefore, their full and proper consideration in public, political and policy-forming debates. It is worth considering the ethico-political questions raised by EV, and whether these might have any relevance for the ODR and its arrangement.

Before going any further, it is worth noting that some commentators, such as Watkinson et al,21 appear to understand EV to mean something slightly different than what was practised in Exeter in the late 1980s, and detailed in the associated protocol.11 They reference the recent guidance issued by National Institute for Health and Clinical Excellence (NICE), and seem to suggest EV is a temporary intervention designed to determine the wishes of the patient in regard to organ donation.22 It may be that they also mean something similar to what Zieler et al term the transformation of an uncontrolled DCD into a controlled DCD, that is, the delaying of cardiac arrest through the provision of life support, and its subsequent withdrawal once appropriate social, ethical and clinical arrangements have been made for donation.7 However, neither Zieler et al nor NICE use the term EV, and I believe this interpretation is a limited account of the practices that it encompasses. The perspective presented here reflects EV as previously practised in Exeter, according to the protocol described by Feest et al,11 and as discussed in the surrounding literature.3–6 23–28

EV, organ donation and the politics of death

EV is an attempt to delay the occurrence of cardiac arrest, which would be the result of the respiratory arrest it actually inhibits. This is done as there is an expectation that the criteria for Brain Stem Death (BSD) will be met if sufficient time is allowed for a determination to be made. As Manara and Jewkes put it, in the case of EV, ‘invasive treatment is not simply prolonged after BSD to allow organ donation. It is specifically started for no indication other than to allow the fulfilment of the criteria for BSD and organ donation’.27 As such, EV is a procedure that exists between the epistemology of BSD and cardiac death. However, when EV was first conceived, organ donation could only occur in cases of BSD and was, therefore, solely concerned with facilitating a BSD determination for the purposes of donation. As DCD is now practiced, EV fulfils some other, slightly different, functions.

First, EV may be pursued in locations where, primarily due to a lack of resources for the rapid removal of organs, DCD procurements are not an option but can facilitate donation in circumstances of BSD. As originally practiced in Exeter, a potentially BSD patient may be subject to EV so that they can be assessed and, if appropriate, donation can be pursued. Second, in locales where DCD is an option patients who are at risk of imminent respiratory arrest and whose treatment is deemed futile may still be electively ventilated in order that a BSD determination might be made or, indeed, in order that BSD might occur. Third, EV may be used to delay cardiac arrest such that an ‘uncontrolled’ DCD might be turned into a ‘controlled’ DCD.7 As better transplantation outcomes are achieved in donations that occur in the context of BSD rather than DCD and in the context of controlled DCD rather than uncontrolled DCD one can see why this practice would be pursued. Thus EV may not simply facilitate organ donation per se but a preference for one form of death over another and for particular forms of donation over others because doing so may increase and improve donation rates and outcomes in specific locales and circumstances.

Lock argues that a ‘ventilator, together with responsible intensive care unit staff, becomes, in effect, a simulacrum for much of the functioning of the lower brain stem, and takes over the involuntary task of breathing for patients who are no longer able to cope independently’.29 EV will enact this simulacrum in specific locales, such as district general hospitals, where DCD is not possible. Where EV protocols previously aimed to facilitate a BSD determination and, thereby, a donation that could not otherwise have occurred, current practices mean that EV may be used to facilitate organ donation in one set of circumstances (BSD) instead of another (DCD). EV may be used to improve donation outcomes by enabling clinicians to prefer one epistemological form of death to another. In such a context, not only dying but also death becomes a process that is inextricably intertwined with the social organisation of medicine and transplant services.

Since its inception, organ transplantation has continually challenged the definition of death and its determination. EV raises further questions. In a comment on the original EV protocol, Wallace suggested that EV is incompatible with the proper diagnosis of death, while McHale considers whether EV might require or imply a third category of death, cognitive death.23 ,28 Introduced, at least in part, for the purpose of facilitating organ donation, BSD criteria are not simply a ‘more objective’ criteria for establishing that death has occurred.30 As BSD criteria cannot be applied to all biologically alive organisms, they cannot be understood as reflecting biological death per se, but as capturing some conceptual, ontological and, perhaps more significantly, moral boundary of a human being.31 iii A comprehensive biological conception of death challenges the notion that death occurs at a point in time. Here, death involves the dissolution of the organism. It is not simply the conclusion of a process called dying, but is, itself, that process.32 In response, Holland argues that our ‘ordinary concept of (human) death’ extends beyond any biological criteria, and recognises the important of consciousness and subjective experience. He concludes that it ‘is not that one or other of the prominent definitions—biological and consciousness-based, respectively—is wrong; rather, the problem lies in the mistaken assumption that death must be defined exclusively in terms of one or the other’.33

In the contemporary milieu, there is no clear ontology of death, rather, there are various philosophical, theological, biomedical and biological perspectives. We must acknowledge the challenges this controversy presents for organ donation and, specifically, the ‘dead donor rule.’ Mistry suggests the rule is little more than a convenience that ‘allows us to keep public policies simple’,15 while Holland notes that it is unclear how the rule applies to those who ‘are in a sense dead and in a sense not dead’.33 Such concerns indicate that death cannot simply be understood purely as a matter for professionals, be they philosophers, bioethicists and/or medical scientists. Questions around death must be recognised as having an ethico-political dimension.

As such, our concern should be with how we respond to individuals who are in such liminal ‘dead and not dead’ states—what Lock calls ‘living cadavers’,29 and what Agamben calls ‘bare life’.34 Our concern should be with how, given the circumstances, these individuals wish to be treated and, therefore, with how those wishes might be given expression and recorded. The questions surrounding the nature and determination of death that are raised by organ donation and EV should be regarded as aspects of our contemporary ‘politics of death’. The controversy regarding death is no longer simply an epistemic or ontological concern, but is now also a moral problem, and it would now be unethical for the state, professional biomedicine or bioethics to impose a determinate definition in an attempt to produce a ‘convenient’ and ‘simple’ policy. Such debates should, therefore, appear in contemporary political discourse about organ donation and, furthermore, be reflected in the structural arrangements we make for donation, such as the ODR.

EV and limitations of the ODR for biocitizenship

The way in which organ donation and transplantation is socially structured and culturally institutionalised is not simply a matter of (bio)ethical analysis, but also of democratic legitimacy. It concerns the relationship between the state and its citizens and is, therefore, a political matter. This much is evident in the 2000 and 2012 reports of the BMA, in some arguments against opt-out ODRs, and in broader calls for greater ‘public engagement’ on the part of bioethics.1 ,2 ,35–37 In the context of a democratic society, the normative arguments of applied (bio)ethics and bioethicists must obtain a broader political, that is, public and professional, legitimacy in order that they might be accepted and instantiated in practice. The ways in which such things might occur range from the single-issue referendum to the local adoption of a policy following consultation with various publics to various degrees. For instance, in the case of moving to an opt-out ODR, it is likely that a broad democratic mandate will be required. Despite the fact that there appears to be a high degree of democratic legitimacy for donation per se, this may not translate into support for specific policies or approaches to donation. It is likely that there would have to be a (renewed) process of consultation, discussion in parliament (likely followed by a free-vote) and, possibly, a referendum before the ODR could be reformed on the basis of an opt-out system.iv

Actual donation rates—64.5% (BSD) and 50.8% (DCD)—lie somewhere between the percentage of the population who reports a willingness to donate, and the percentage that is registered with the ODR.1 ,17 It would be simplistic to point to this disconnect and argue for an opt-out ODR on the assumption that undertaking decisions about donation in or around the point of death is suboptimal. Having 30% of the UK population registered as organ donors is greater than many other national contexts, such as Spain, which have higher actual donation rates.17 As Holland suggests with regard to attitudes towards death,33 we might suppose that the simplistic nature of the ODR and surveys on attitudes towards donation may hide the complexity of public opinions. Therefore, as a recent Nuffield Bioethics report argued,38 it may be that the ODR should be reconstituted such that it can record a more complex array of attitudes towards donation.

Taking note of public attitudes regarding organ donation can lead to the development of more complex frameworks for donation. Consider, for instance, the way in which Israel prioritises the allocation of transplantable organs to those who have previously registered to donate their organs.39 Such an approach demonstrates how the social structures of organ donation can be configured according to broader ethico-political concerns, such as solidarity, and not simply on the basis of individualist bioethics.40 However, on the basis of the information given in the article, one might think that a greater degree of public debate and deliberation may have been warranted. Wall et al provide an example of such engagement in the development of a protocol to govern the uncontrolled DCD of potential donors who die outside of a clinical setting. Their article also provides evidence of the potential offered by social scientific research to further bioethical ends. Their approach involved a ‘three-way partnership with government officials, subject experts and the community [who were mutually engaged through a series of] … informal consultations, expert panels, focus groups and town hall style meetings’.41 The data collected was used to derive a ‘clinically appropriate, ethically sound protocol for out-of-hospital settings … [that] is likely to be accepted by NYC residents’41 precisely because of the manner in which it was produced.

What such discussions indicate is that what is required is not simply a more sophisticated ODR. Rather, what is required is a greater level of public and political engagement with the issue of organ donation. A more responsive ODR is one aspect of this engagement. In the first instance, we might note that it is highly regrettable that the UK ODR does not register the negative attitude of individuals towards donation. In official discourse, non-registration is not taken to mean a lack of willingness to donate. Nevertheless, it may be taken as such by the family of the deceased when asked about the potential donor's wishes. Furthermore, the ODR should be structured to record the uncertainties of individuals who simply do not know if they want to donate, or who may wish for their families (or other ‘next-of-kin’) to make a decision on their behalf if donation became a possibility. In addition, as there are now two distinct ways in which one might become an organ donor, we might consider whether all individuals are equally willing to donate under DCD and BSD protocols. If not, then the ODR should record the willingness of individuals to donate in each circumstance. It is also likely that the willingness of individuals to donate under EV protocols will vary. It may be that there should be a wider public debate about, and appreciation for, EV before any attempt to institutionalise the practice is made. Such a debate might uncover such a diversity of opinion that the ODR must be reconfigured in order to record the explicit consent of individuals to EV. Present contemplation of EV not only adds weight to calls to reform the ODR along the lines suggested in the Nuffield Council on Bioethics, but also exposes the need for biopolitical, as well as bioethical, debates on the issue of EV.38

Conclusion

‘Electively ventilated’ or not, the potential non-living organ donor has a ‘hybrid status—that of a dead-person-in-a-living-body’.29 The living body's options are limited, but the dead person's wishes may still be respected. EV aims to enact the latter by using modern medical technology to take advantage of the former. However, if we are to ethically facilitate the wishes of the dead we must first ensure we know what they are. Thus, what I have called the politics of death is, in fact, one aspect of what Rose calls the politics of life itself. He argues ‘we should conceptualise the economy of contemporary biopolitics as operating according to the logics of vitality, not those of mortality. While biopower, today, certainly has its circuits of exclusion, letting die is not making die. This is not a politics of death, though death suffices it and haunts it, nor even a politics of health and illness; it is a matter of the government of life’.42

It is concern for the government of life, not death, that animates calls for EV and the ODR. EV, the ODR and organ donation itself are biopolitical practices and, as such, they are ‘largely positive and productive; about making live not letting die’.43 Though death suffices and haunts organ donation, the ODR and, particularly EV, they are, or should be, about carrying out the wishes of the no-longer-living person with regard to their still-living body. This should not be brought about through the state, in concord with biomedical and bioethical expertise, imposing its own ‘solution’, but through a legitimate democratic process and a policy of public engagement, particularly on the part of bioethics.

Scheper-Hughes suggests, and we might say the same of EV, that BSD is a ‘form of medical triage and lifeboat ethics’.44 This can and should be analysed through the lens of applied philosophical (bio)ethics. Nevertheless, EV, BSD and organ donation practices more generally can also be addressed through the lens of biopolitics. Such approaches encompass ‘the ethical considerations deemed relevant by participants—not just patients and their families, but also researchers, clinicians and regulators…—in their actual conduct of themselves and their lives in relation to the dilemmas that they face and the judgments and decisions they must make… Ethics [is] here understood as a way of understanding, fashioning, and managing ourselves’.42

One way to do this is, to extend our ability to understand, fashion and manage ourselves in respect of EV and organ donation, is through the (re)establishment of an ODR along the lines discussed, and through the enactment of a broader political and discursive engagement with the public(s) of bioethics; with patients, families, donors, recipients, the various professionals involved in organ donation and regulators. Questions of death and dying, the cessation of our social, subjective and biological existence, are aspects of our politics, and so the answers we offer to questions such as ‘Can EV be an ethical part of organ donation?’ cannot be given in solely scientific, philosophical or even theological terms, but must also be given in biopolitical terms. If they are to be ethical they must also be constituted as and by forms of engagement with ‘the polity’, that is, with those who would, and would not, participate.

Acknowledgments

The author would like to thank Dr Bob Taylor for his helpful discussion and guidance on the art and science of EV; Dr Mairi Levitt and Prof Richard Ashcroft for their comments on an early draft. The helpful input and peer review offered by the editors, an anonymous reviewer and, in particular, Professor Amy T Campbell.

References

Footnotes

Other content recommended for you